Abivax Book Value Per Share vs Average Payables Analysis

ABVX Stock

102.42 1.87 1.79%

Abivax SA financial indicator trend analysis is way more than just evaluating Abivax SA American prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Abivax SA American is a good investment. Please check the relationship between Abivax SA Book Value Per Share and its Average Payables accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abivax SA American. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

Book Value Per Share vs Average Payables

Book Value Per Share vs Average Payables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Abivax SA American Book Value Per Share account and Average Payables. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Abivax SA's Book Value Per Share and Average Payables is 0.42. Overlapping area represents the amount of variation of Book Value Per Share that can explain the historical movement of Average Payables in the same time period over historical financial statements of Abivax SA American, assuming nothing else is changed. The correlation between historical values of Abivax SA's Book Value Per Share and Average Payables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Book Value Per Share of Abivax SA American are associated (or correlated) with its Average Payables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Average Payables has no effect on the direction of Book Value Per Share i.e., Abivax SA's Book Value Per Share and Average Payables go up and down completely randomly.

Correlation Coefficient

0.42

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Most indicators from Abivax SA's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Abivax SA American current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abivax SA American. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

At this time, Abivax SA's Selling General Administrative is fairly stable compared to the past year. Tax Provision is expected to grow at the current pace this year, whereas Issuance Of Capital Stock is likely to drop slightly above 412.3 K in 2025.

	2022	2023	2024	2025 (projected)
Interest Expense	6.9M	13.8M	12.4M	13.1M
Depreciation And Amortization	485K	707K	1.1M	1.2M

Interest Expense Depreciation And Amortization

Abivax SA fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Retained Earnings	Short Term Debt	Intangible Assets	Common Stock	Other Assets
Total Assets		0.63	0.43	0.72	0.8	0.52	-0.92	0.84	0.94	0.73	0.5	0.95	0.93	-0.85	0.69	0.12	0.74	0.83	0.82	0.75	0.94	-0.71	0.41	0.5	0.82	-0.03
Short Long Term Debt Total	0.63		0.25	0.97	0.17	0.87	-0.42	0.93	0.78	0.68	0.81	0.74	0.75	-0.7	0.93	-0.35	0.96	0.84	0.87	0.98	0.77	-0.94	0.89	0.37	0.9	0.19
Other Current Liab	0.43	0.25		0.32	0.4	0.16	-0.43	0.31	0.42	0.47	0.03	0.42	0.23	-0.23	0.26	0.11	0.24	0.32	0.26	0.29	0.41	-0.19	-0.05	-0.01	0.32	0.26
Total Current Liabilities	0.72	0.97	0.32		0.32	0.89	-0.55	0.96	0.85	0.76	0.78	0.83	0.8	-0.77	0.96	-0.23	0.92	0.92	0.95	0.98	0.85	-0.97	0.88	0.39	0.96	0.21
Total Stockholder Equity	0.8	0.17	0.4	0.32		0.2	-0.96	0.49	0.75	0.54	0.17	0.78	0.58	-0.63	0.36	0.47	0.33	0.6	0.55	0.33	0.75	-0.34	-0.04	0.52	0.52	-0.26
Property Plant And Equipment Net	0.52	0.87	0.16	0.89	0.2		-0.4	0.83	0.7	0.44	0.83	0.68	0.57	-0.8	0.97	-0.17	0.8	0.88	0.89	0.87	0.71	-0.94	0.85	0.58	0.89	-0.07
Net Debt	-0.92	-0.42	-0.43	-0.55	-0.96	-0.4		-0.7	-0.9	-0.66	-0.37	-0.91	-0.75	0.79	-0.57	-0.25	-0.57	-0.77	-0.72	-0.57	-0.89	0.55	-0.18	-0.6	-0.71	0.22
Accounts Payable	0.84	0.93	0.31	0.96	0.49	0.83	-0.7		0.94	0.76	0.78	0.92	0.88	-0.85	0.94	-0.16	0.96	0.95	0.96	0.98	0.94	-0.94	0.76	0.54	0.98	0.03
Cash	0.94	0.78	0.42	0.85	0.75	0.7	-0.9	0.94		0.79	0.65	1.0	0.88	-0.88	0.85	0.01	0.86	0.95	0.93	0.87	1.0	-0.84	0.56	0.6	0.94	-0.06
Non Current Assets Total	0.73	0.68	0.47	0.76	0.54	0.44	-0.66	0.76	0.79		0.37	0.78	0.73	-0.46	0.62	-0.08	0.66	0.69	0.72	0.73	0.78	-0.65	0.56	0.02	0.74	0.5
Non Currrent Assets Other	0.5	0.81	0.03	0.78	0.17	0.83	-0.37	0.78	0.65	0.37		0.63	0.62	-0.72	0.83	-0.24	0.81	0.76	0.78	0.81	0.66	-0.83	0.74	0.6	0.78	-0.17
Cash And Short Term Investments	0.95	0.74	0.42	0.83	0.78	0.68	-0.91	0.92	1.0	0.78	0.63		0.88	-0.88	0.83	0.09	0.83	0.94	0.92	0.85	1.0	-0.82	0.53	0.61	0.92	-0.08
Net Receivables	0.93	0.75	0.23	0.8	0.58	0.57	-0.75	0.88	0.88	0.73	0.62	0.88		-0.8	0.72	-0.01	0.82	0.8	0.82	0.82	0.88	-0.78	0.59	0.39	0.83	0.1
Good Will	-0.85	-0.7	-0.23	-0.77	-0.63	-0.8	0.79	-0.85	-0.88	-0.46	-0.72	-0.88	-0.8		-0.86	-0.03	-0.78	-0.93	-0.9	-0.79	-0.89	0.84	-0.55	-0.79	-0.89	0.32
Common Stock Shares Outstanding	0.69	0.93	0.26	0.96	0.36	0.97	-0.57	0.94	0.85	0.62	0.83	0.83	0.72	-0.86		-0.18	0.9	0.96	0.96	0.95	0.85	-0.98	0.84	0.59	0.97	-0.02
Short Term Investments	0.12	-0.35	0.11	-0.23	0.47	-0.17	-0.25	-0.16	0.01	-0.08	-0.24	0.09	-0.01	-0.03	-0.18		-0.29	-0.06	-0.02	-0.26	0.06	0.15	-0.35	0.1	-0.1	-0.19
Non Current Liabilities Total	0.74	0.96	0.24	0.92	0.33	0.8	-0.57	0.96	0.86	0.66	0.81	0.83	0.82	-0.78	0.9	-0.29		0.87	0.88	0.98	0.86	-0.9	0.76	0.54	0.91	-0.02
Other Current Assets	0.83	0.84	0.32	0.92	0.6	0.88	-0.77	0.95	0.95	0.69	0.76	0.94	0.8	-0.93	0.96	-0.06	0.87		0.98	0.91	0.95	-0.94	0.71	0.66	0.99	-0.1
Other Stockholder Equity	0.82	0.87	0.26	0.95	0.55	0.89	-0.72	0.96	0.93	0.72	0.78	0.92	0.82	-0.9	0.96	-0.02	0.88	0.98		0.93	0.94	-0.97	0.78	0.59	0.99	-0.01
Total Liab	0.75	0.98	0.29	0.98	0.33	0.87	-0.57	0.98	0.87	0.73	0.81	0.85	0.82	-0.79	0.95	-0.26	0.98	0.91	0.93		0.87	-0.96	0.84	0.46	0.96	0.11
Total Current Assets	0.94	0.77	0.41	0.85	0.75	0.71	-0.89	0.94	1.0	0.78	0.66	1.0	0.88	-0.89	0.85	0.06	0.86	0.95	0.94	0.87		-0.85	0.56	0.61	0.94	-0.07
Retained Earnings	-0.71	-0.94	-0.19	-0.97	-0.34	-0.94	0.55	-0.94	-0.84	-0.65	-0.83	-0.82	-0.78	0.84	-0.98	0.15	-0.9	-0.94	-0.97	-0.96	-0.85		-0.89	-0.51	-0.97	-0.07
Short Term Debt	0.41	0.89	-0.05	0.88	-0.04	0.85	-0.18	0.76	0.56	0.56	0.74	0.53	0.59	-0.55	0.84	-0.35	0.76	0.71	0.78	0.84	0.56	-0.89		0.19	0.78	0.32
Intangible Assets	0.5	0.37	-0.01	0.39	0.52	0.58	-0.6	0.54	0.6	0.02	0.6	0.61	0.39	-0.79	0.59	0.1	0.54	0.66	0.59	0.46	0.61	-0.51	0.19		0.57	-0.81
Common Stock	0.82	0.9	0.32	0.96	0.52	0.89	-0.71	0.98	0.94	0.74	0.78	0.92	0.83	-0.89	0.97	-0.1	0.91	0.99	0.99	0.96	0.94	-0.97	0.78	0.57		0.01
Other Assets	-0.03	0.19	0.26	0.21	-0.26	-0.07	0.22	0.03	-0.06	0.5	-0.17	-0.08	0.1	0.32	-0.02	-0.19	-0.02	-0.1	-0.01	0.11	-0.07	-0.07	0.32	-0.81	0.01

Click cells to compare fundamentals

Abivax SA Account Relationship Matchups

Abivax SA fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	71.3M	109.2M	75.5M	327.1M	205.2M	106.4M
Short Long Term Debt Total	34.0M	51.7M	49.2M	55.5M	97.4M	102.2M
Other Current Liab	1.8M	3.7M	5.7M	9.8M	532K	558.6K
Total Current Liabilities	19.4M	32.3M	51.5M	70.0M	92.8M	97.5M
Total Stockholder Equity	17.9M	25.9M	7.2M	196.0M	40.6M	53.7M
Property Plant And Equipment Net	100K	93K	323K	877K	2.7M	2.8M
Net Debt	4.7M	(9.0M)	22.3M	(196.5M)	(46.9M)	(44.5M)
Accounts Payable	17.4M	18.6M	15.5M	47.2M	43.8M	46.0M
Cash	29.3M	60.7M	26.9M	251.9M	144.2M	151.4M
Non Current Assets Total	33.6M	35.2M	39.4M	41.1M	34.6M	38.0M
Non Currrent Assets Other	1.2M	2.7M	(2K)	2.9M	6.7M	7.1M
Cash And Short Term Investments	29.3M	60.7M	27.0M	261.0M	144.2M	151.4M
Net Receivables	8.0M	8.3M	8.3M	19.1M	15.7M	8.4M
Common Stock Shares Outstanding	14.3M	15.5M	19.1M	43.1M	63.0M	66.2M
Liabilities And Stockholders Equity	71.3M	110.4M	75.5M	327.1M	205.2M	106.6M
Non Current Liabilities Total	34.0M	51.0M	16.9M	61.0M	71.8M	75.4M
Other Current Assets	325K	721K	915K	11.8M	10.8M	11.3M
Other Stockholder Equity	55.3M	107.6M	150.5M	478.2M	478.9M	502.9M
Total Liab	53.4M	83.3M	68.4M	131.1M	164.6M	172.9M
Total Current Assets	37.7M	75.2M	36.2M	286.0M	170.7M	179.2M
Retained Earnings	(37.6M)	(81.8M)	(143.5M)	(282.9M)	(438.9M)	(416.9M)
Short Term Debt	12K	10.2M	30.0M	10.6M	43.8M	46.0M
Intangible Assets	98K	(647K)	(13.1M)	6.6M	6.6M	6.9M
Common Stock	143K	168K	223K	629K	633K	664.7K
Inventory	1.1M	4M	12.2M	(5.9M)	(6.8M)	(6.4M)
Accumulated Other Comprehensive Income	289K	(37.3M)	1K	112K	(75K)	(78.8K)
Long Term Debt	28.4M	53.4M	36.6M	44.7M	52.2M	43.3M
Net Invested Capital	51.9M	89.1M	54.8M	250.9M	135.6M	114.0M
Property Plant And Equipment Gross	100K	548K	841K	2.4M	4.0M	4.2M
Short Long Term Debt	5.5M	7K	9.5M	10.2M	42.8M	45.0M
Capital Stock	143K	168K	223K	629K	633K	351.6K
Non Current Liabilities Other	8K	5.7M	(1K)	3.3M	13.0M	13.7M
Net Working Capital	12.7M	54.0M	20.2M	215.9M	77.8M	70.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

VOO	Vanguard SP 500
XLK	Technology Select Sector
XLV	Health Care Select

Additional Tools for Abivax Stock Analysis

When running Abivax SA's price analysis, check to measure Abivax SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abivax SA is operating at the current time. Most of Abivax SA's value examination focuses on studying past and present price action to predict the probability of Abivax SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abivax SA's price. Additionally, you may evaluate how the addition of Abivax SA to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Abivax Book Value Per Share vs Average Payables Analysis

Book Value Per Share vs Average Payables

Book Value Per Share vs Average Payables Correlation Analysis

Correlation Coefficient

Book Value Per Share

Average Payables

Abivax SA fundamental ratios Correlations

Abivax SA Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Abivax SA fundamental ratios Accounts

Also Currently Popular

Additional Tools for Abivax Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 0.99	Other Current Assets
Common Stock	+ 0.99	Other Stockholder Equity
Total Liab	+ 0.98	Short Long Term Debt Total

Retained Earnings	- 0.98	Common Stock Shares Outstanding
Common Stock	- 0.97	Retained Earnings
Retained Earnings	- 0.97	Other Stockholder Equity
Retained Earnings	- 0.97	Total Current Liabilities
Retained Earnings	- 0.96	Total Liab
Net Debt	- 0.96	Total Stockholder Equity